Guidance for industry : requalification method for reentry of blood donors deferred because of reactive test results for antibody to hepatitis B core antigen (anti-HBc).

Guidance for industry : requalification method for reentry of blood donors deferred because of reactive test results for antibody to hepatitis B core antigen (anti-HBc).

Saved in:
Bibliographic Details
Imprint:Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2008]
Description:i, 8 p. : digital, PDF file.
Language:English
Subject:
Blood donors.
Hepatitis associated antigen.
Blood donors.
Hepatitis associated antigen.
Format: E-Resource U.S. Federal Government Document Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/7730673
Hidden Bibliographic Details
Varying Form of Title:Requalification method for reentry of blood donors deferred because of reactive test results for antibody to hepatitis B core antigen (anti-HBc)
Other authors / contributors:Center for Biologics Evaluation and Research (U.S.)
Notes:Title from PDF title page (viewed on Apr. 24, 2009).
"Draft guidance".
"May 2008".
Includes bibliographical references (p. 6-7).
Mode of access: Internet at the FDA CBER Web site. Address as of 4/24/09: http://www.fda.gov/cber/gdlns/reentrybld.pdf ; current access is available via PURL.
GPO item no.:0499-T-02 (online)
Govt.docs classification:HE 20.4802:R 29

Similar Items